Literature DB >> 6254396

Responses of mouse spleen morphology to the growth of subcutaneously injected virally transformed cells.

R L Nutter, D S Gridley, J M Slater, P J McMillan.   

Abstract

The changes in the fractional volume of six structural components in the spleens of Balb/C mice injected with Herpes simplex virus Type 2-transformed cells (H238 tumor cells) were quantitated during progressive tumor growth. Spleen stereology was performed at three time intervals during the early stages of tumor development. The results revealed that the volume of the compact myeloid tissue and reaction center of lymphoid nodules increased about four- to five-fold from 10 to 33 days after H238 tumor cell injection. A progressive increase was also seen in the red pulp volume. Although an increase in volume of the marginal zones around the lymphoid nodules was evident early during the test period, by day 33 the mean value was similar to the control value. These results indicate that the spleen undergoes significant morphological changes in three splenic components during progressive growth of a tumor produced by subcutaneous injection of a virally-transformed cell line.

Entities:  

Mesh:

Year:  1980        PMID: 6254396     DOI: 10.1002/ar.1091970310

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  3 in total

1.  Effects of the removal of adherent and phagocytic cells on the spleen cell lymphoproliferative response of tumor-bearing mice.

Authors:  A M Hyde; R B Stagg; R McEachron; R L Nutter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

2.  Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance.

Authors:  Elizabeth M Steinert; Jason M Schenkel; Kathryn A Fraser; Lalit K Beura; Luke S Manlove; Botond Z Igyártó; Peter J Southern; David Masopust
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

3.  Protective effect of hydrogen-rich saline against radiation-induced immune dysfunction.

Authors:  Sanhu Zhao; Yanyong Yang; Wen Liu; Zhiqiang Xuan; Shouming Wu; Shunfei Yu; Ke Mei; Yijuan Huang; Pei Zhang; Jianming Cai; Jin Ni; Yaoxian Zhao
Journal:  J Cell Mol Med       Date:  2014-03-12       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.